227
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Impacts of the COVID-19 public health restrictions on substance use, mental health, and psychosocial functioning among individuals with alcohol use disorder

, , , , , , , , , , ORCID Icon & show all
Pages 712-723 | Received 19 Dec 2021, Accepted 04 Oct 2022, Published online: 23 Nov 2022

References

  • Fernandes N Economic effects of coronavirus outbreak (COVID-19) on the world economy. SSRN WP-1240-E. 2020 Mar 22 [accessed 2021 Dec 19]. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3557504.
  • Pappa S, Ntella V, Giannakas T, Giannakoulis VG, Papoutsi E, Katsaounou P. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis. Brain Behav Immun. 2020;88:901–07.
  • Santabárbara J, Lasheras I, Lipnicki DM, Bueno-Notivol J, Pérez-Moreno M, López-Antón R, De la Cámara C, Lobo A, Gracia-García P. Prevalence of anxiety in the COVID-19 pandemic: an updated meta-analysis of community-based studies. Progr Neuro-Psychopharmacol Biol Psychiatry. 2021;109:110207. doi:10.1016/j.pnpbp.2020.110207.
  • Gobbi S, Plomecka M, Ashraf Z, Radziński P, Neckels R, Lazzeri S, Dedić A, Bakalović A, Hrustić L, Skórko B, et al. Worsening of pre-existing psychiatric conditions during the COVID-19 pandemic. Front Psychiatry. 2020;11:581426.
  • Li W, Zhao N, Yan X, Zou S, Wang H, Li Y, Xu X, Du X, Zhang L, Zhang Q, et al. The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic. Transl Psychiatry. 2021;11:75.
  • Czeisler MÉ, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, Robbins R, Facer-Childs ER, Barger LK, et al. Mental health, substance use, and suicidal ideation during the COVID-19 pandemic — United States, June 24–30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14 [accessed 2021 Dec 19];69:1049–57. doi:10.15585/mmwr.mm6932a1.
  • Irizar P, Jones A, Christiansen P, Goodwin L, Gage SH, Roberts C, Knibb G, Cooke R, Rose AK. Longitudinal associations with alcohol consumption during the first COVID-19 lockdown: associations with mood, drinking motives, context of drinking, and mental health. Drug Alcohol Depend. 2021;226:108913.
  • Koopmann A, Georgiadou E, Reinhard I, Müller A, Lemenager T, Kiefer F, Hillemacher T. The effects of the lockdown during the COVID-19 pandemic on alcohol and tobacco consumption behavior in Germany. Eur Addict Res. 2021;27:242–56.
  • Benzano D, Ornell F, Schuch JB, Pechansky F, Sordi AO, von Diemen L, Kessler FHP. Clinical vulnerability for severity and mortality by COVID-19 among users of alcohol and other substances. Psychiatry Res. 2021;300:113915.
  • Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2021;26:30–39.
  • Columb D, Hussain R, O’Gara C. Addiction psychiatry and COVID-19-impact on patients and service provision. Ir J Psychol Med. 2020;37:164–68.
  • Melamed OC, Hauck TS, Buckley L, Selby P, Mulsant BH. COVID-19 and persons with substance use disorders: inequities and mitigation strategies. Subst Abus. 2020;41:286–91.
  • Capasso A, Jones AM, Ali SH, Foreman J, Tozan Y, DiClemente RJ. Increased alcohol use during the COVID-19 pandemic: the effect of mental health and age in a cross-sectional sample of social media users in the U.S. Prev Med. 2021;145:106422.
  • Garnett C, Jackson S, Oldham M, Brown J, Steptoe A, Fancourt D. Factors associated with drinking behaviour during COVID-19 social distancing and lockdown among adults in the UK. Drug Alcohol Depend. 2021;219:108461.
  • Gratz KL, Scamaldo KM, Vidaña AG, Richmond JR, Tull MT. Prospective interactive influence of financial strain and emotional nonacceptance on problematic alcohol use during the COVID-19 pandemic. Am J Drug Alcohol Abuse. 2021;47:107–16.
  • Weerakoon SM, Jetelina KK, Knell G, Messiah SE. COVID-19 related employment change is associated with increased alcohol consumption during the pandemic. Am J Drug Alcohol Abuse. 2021;47:730–36.
  • Clay JM, Parker MO. Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? Lancet Public Health. 2020;5:e259.
  • Mallet J, Dubertret C, Le Strat Y. Addictions in the COVID-19 era: current evidence, future perspectives a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2020;106:110070.
  • Balhara YPS, Singh S, Narang P. Effect of lockdown following COVID-19 pandemic on alcohol use and help-seeking behavior: observations and insights from a sample of alcohol use disorder patients under treatment from a tertiary care center. Psychiatry Clin Neurosci. 2020;74:440–41.
  • Mellis AM, Potenza MN, Hulsey JN. COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns. J Subst Abuse Treat. 2021;121:108180.
  • Pagano A, Hosakote S, Kapiteni K, Straus ER, Wong J, Guydish JR. Impacts of COVID-19 on residential treatment programs for substance use disorder. J Subst Abuse Treat. 2021;123:108255.
  • Bergman BG, Kelly JF. Online digital recovery support services: an overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond. J Subst Abuse Treat. 2021;120:108152.
  • McDonnell A, MacNeill C, Chapman B, Gilbertson N, Reinhardt M, Carreiro S. Leveraging digital tools to support recovery from substance use disorder during the COVID-19 pandemic response. J Subst Abuse Treat. 2021;124:108226.
  • Jacob L, Smith L, Armstrong NC, Yakkundi A, Barnett Y, Butler L, McDermott DT, Koyanagi A, Shin JI, Meyer J, et al. Alcohol use and mental health during COVID-19 lockdown: a cross-sectional study in a sample of UK adults. Drug Alcohol Depend. 2021;219:108488.
  • Killgore WDS, Cloonan SA, Taylor EC, Lucas DA, Dailey NS. Alcohol dependence during COVID-19 lockdowns. Psychiatry Res. 2021;296:113676.
  • Muruganandam P, Neelamegam S, Menon V, Alexander J, Chaturvedi SK. COVID-19 and severe mental illness: impact on patients and its relation with their awareness about COVID-19. Psychiatry Res. 2020;291:113265.
  • Asmundson GJG, Paluszek MM, Landry CA, Rachor GS, McKay D, Taylor S. Do pre-existing anxiety-related and mood disorders differentially impact COVID-19 stress responses and coping? J Anxiety Disord. 2020;74:102271.
  • Zaccari V, D’Arienzo MC, Caiazzo T, Magno A, Amico G, Mancini F. Narrative review of COVID-19 impact on obsessive-compulsive disorder in child, adolescent and adult clinical populations. Front Psychiatry. 2021;12:673161.
  • Gilbert PA, Soweid L, Kersten SK, Brown G, Zemore SE, Mulia N, Skinstad AH. Maintaining recovery from alcohol use disorder during the COVID-19 pandemic: the importance of recovery capital. Drug Alcohol Depend. 2021;229:109142.
  • Hurley EA, Piña K, Cegielski V, Noel-MacDonnell JR, Miller MK. Recovering from substance use disorders during the early months of the COVID-19 pandemic: a mixed-methods longitudinal study of women in Kansas City. J Subst Abuse Treat. 2021;129:108378.
  • Hochstatter KR, Akhtar WZ, Dietz S, Pe-Romashko K, Gustafson DH, Shah DV, Krechel S, Liebert C, Miller R, El-Bassel N, et al. Potential influences of the covid-19 pandemic on drug use and HIV care among people living with HIV and substance use disorders: experience from a pilot mHealth intervention. AIDS Behav. 2021;25:354–59.
  • Barrio P, Baldaquí N, Andreu M, Kilian C, Rehm J, Gual A, Manthey J. Abstinence among alcohol use disorder patients during the COVID-19 pandemic: insights from Spain. Alcohol Clin Exp Res. 2021;45:802–07.
  • Kim JU, Majid A, Judge R, Crook P, Nathwani R, Selvapatt N, Lovendoski J, Manousou P, Thursz M, Dhar A, et al. Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder. Lancet Gastroenterol Hepatol. 2020;5:886–87.
  • Substance Abuse and Mental Health Services Administration [SAMHSA]. Considerations for the care and treatment of mental and substance use disorders in the COVID-19. 2020. https://www.samhsa.gov/sites/default/files/considerations-care-treatment-mental-substance-use-disorders-covid19.pdf.
  • Centers for medicare & medicaid services (CMS) and substance abuse and mental health services administration (SAMHSA): leveraging existing health and disease management programs to provide mental health and substance use disorder resources during the COVID-19 Public Health Emergency (PHE). 2020. https://www.cms.gov/CCIIO/Programs-and-Initiatives/Health-Insurance-Marketplaces/Downloads/Mental-Health-Substance-Use-Disorder-Resources-COVID-19.pdf.
  • Ministry of Health. COVID-19 guidance: mental health and addictions service providers in community settings. Ontario; 2020. https://www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/2019_MHAS_Community_guidance.pdf.
  • Collins RL, Parks GA, Marlatt GA. Social determinants of alcohol consumption: the effects of social interaction and model status on the self-administration of alcohol. J Consult Clin Psychol. 1985;53:189–200.
  • Meister SR, Barker B, Flores Pajot M-C. Heavy episodic drinking among post-secondary students: influencing factors and implications. Ottawa (Canada): Canadian Centre on Substance Use and Addiction; 2018.
  • Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2019 national survey on drug use and health. Rockville (USA): Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2020. HHS Publication No. PEP20-07-01-001, NSDUH Series H-55.
  • First MB, Williams JBW, Karg RS, Spitzer RL. Structured clinical interview for DSM-5 disorders – clinician version (SCID-5-CV). American Psychiatric Association Publishing; 2015.
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–13.
  • Spitzer RL, Kroenke K, Williams JBW, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–97.
  • Nylund KL, Asparouhov T, Muthén BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equation Model. 2007;14:535–69.
  • Epifanio MS, Andrei F, Mancini G, Agostini F, Piombo MA, Spicuzza V, Riolo M, Lavanco G, Trombini E, La Grutta S. The impact of COVID-19 pandemic and lockdown measures on quality of life among Italian general population. J Clin Med. 2021;10:289.
  • Necho M, Tsehay M, Birkie M, Biset G, Tadesse E. Prevalence of anxiety, depression, and psychological distress among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Int J Soc Psychiatry. 2021;67:207640211003121. doi:10.1177/00207640211003121.
  • Martinotti G, Alessi MC, Di Natale C, Sociali A, Ceci F, Lucidi L, Picutti E, Di Carlo F, Corbo M, Vellante F, et al. Psychopathological burden and quality of life in substance users during the COVID-19 lockdown period in Italy. Front Psychiatry. 2020;11:572245.
  • McKnight-Eily LR, Okoro CA, Strine TW, Verlenden J, Hollis ND, Njai R, Mitchell EW, Board A, Puddy R, Thomas C. Racial and ethnic disparities in the prevalence of stress and worry, mental health conditions, and increased substance use among adults during the COVID-19 pandemic — United States, April and May 2020. MMWR Morb Mortal Wkly Rep. 2021 Feb 5 [accessed 2021 Dec 19];70:162–66.
  • Eaton LA, Driffin DD, Kegler C, Smith H, Conway-Washington C, White D, Cherry C. The role of stigma and medical mistrust in the routine health care engagement of black men who have sex with men. Am J Public Health. 2015;105:e75–82.
  • McPhee MD, Keough MT, Rundle S, Heath LM, Wardell JD, Hendershot CS. Depression, environmental reward, coping motives and alcohol consumption during the COVID-19 pandemic. Front Psychiatry. 2020;11:574676. doi:10.3389/fpsyt.2020.574676.
  • Callinan S, Mojica-Perez Y, Wright C, Livingston M, Kuntsche S, Laslett AM, Room R, Kuntsche E. Purchasing, consumption, demographic and socioeconomic variables associated with shifts in alcohol consumption during the COVID-19 pandemic. Drug Alcohol Rev. 2021;40:183–91.
  • Jaffe AE, Kumar SA, Ramirez JJ, DiLillo D. Is the COVID-19 pandemic a high-risk period for college student alcohol use? A comparison of three spring semesters. Alcohol Clin Exp Res. 2021;45:854–63.
  • Cerdá M, Tracy M, Galea S. A prospective population based study of changes in alcohol use and binge drinking after a mass traumatic event. Drug Alcohol Depend. 2011;115:1–8.
  • Wu P, Liu X, Fang Y, Fan B, Fuller CJ, Guan Z, Yao Z, Kong J, Lu J, Litvak IJ. Alcohol abuse/dependence symptoms among hospital employees exposed to a SARS outbreak. Alcohol Alcohol. 2008;43:706–12.
  • Schmidt RA, Genois R, Jin J, Vigo D, Rehm J, Rush B. The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: a systematic review. Drug Alcohol Depend. 2021;228:109065.
  • Gorka SM, Ali B, Daughters SB. The role of distress tolerance in the relationship between depressive symptoms and problematic alcohol use. Psychol Addict Behav. 2012;26:621–26.
  • Holahan CJ, Moos RH, Holahan CK, Cronkite RC, Randall PK. Drinking to cope, emotional distress and alcohol use and abuse: a ten-year model. J Stud Alcohol Drugs. 2001;62:190–98.
  • Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4:231–44.
  • MacMillan T, Corrigan MJ, Coffey K, Tronnier CD, Wang D, Krase K. Exploring factors associated with alcohol and/or substance use during the COVID-19 pandemic. Int J Ment Health Addict. 2021;1:10.
  • Wardell JD, Kempe T, Rapinda KK, Single A, Bilevicius E, Frohlich JR, Hendershot CS, Keough MT. Drinking to cope during COVID-19 pandemic: the role of external and internal factors in coping motive pathways to alcohol use, solitary drinking, and alcohol problems. Alcohol Clin Exp Res. 2020;44:2073–83.
  • Rogers AH, Shepherd JM, Garey L, Zvolensky MJ. Psychological factors associated with substance use initiation during the COVID-19 pandemic. Psychiatry Res. 2020;293:113407.
  • Acuff SF, Tucker JA, Murphy JG. Behavioral economics of substance use: understanding and reducing harmful use during the COVID-19 pandemic. Exp Clin Psychopharmacol. 2021;29:739–49. doi:10.1037/pha0000431.
  • Dziak JJ, Lanza ST, Tan X. Effect size, statistical power and sample size requirements for the bootstrap likelihood ratio test in latent class analysis. Struct Equ Modeling. 2014;21:534–52.
  • Yazdi K, Fuchs-Leitner I, Rosenleitner J, Gerstgrasser NW. Impact of the COVID-19 pandemic on patients with alcohol use disorder and associated risk factors for relapse. Front Psychiatry. 2020;11:620612.
  • Testino G, Vignoli T, Patussi V, Allosio P, Amendola MF, Aricò S, Baselice A, Balbinot P, Campanile V, Fanucchi T, et al. Alcohol use disorder in the COVID-19 era: position paper of the Italian Society on Alcohol (SIA). Addict Biol. 2022;27:e13090.
  • Gliske K, Welsh JW, Braughton JE, Waller LA, Ngo QM. Telehealth services for substance use disorders during the COVID-19 pandemic: longitudinal assessment of intensive outpatient programming and data collection practices. JMIR Ment Health. 2022;9:e36263.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.